EUCTR2015-003266-87-PL进行中（未招募）1 期
A multicenter, randomized, open label, parallel group study comparing pre-discharge and posT-discharge tReatment initiation with LCZ696 in heArt failure patieNtS with reduced ejectIon-fracTion hospItalized for an acute decOmpensation eveNt (ADHF) - the TRANSITION study
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients hospitalized due to acute decompensated HF episode (ADHF)
- •- Diagnosis of HF New York Heart Association class II-to-IV and reduced ejection fraction
- •- Patients did not receive any IV vasodilators (except nitrates), and/or any IV inotropic therapy from the time of presentation for ADHF to randomization
- •- Stabilized (while in the hospital) for at least 24 hours leading to randomization
- •- Other protocol-defined inclusion criteria may apply.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 500
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 500
排除标准
- •- Symptomatic hypotension and/or a SBP < 110 mm Hg or SBP > 180 mm Hg prior to randomization
- •- End stage renal disease at ccreening; or estimated GFR < 30 mL/min/1.73 m2 as measured by (MDRD) formula at randomization.
- •- Serum potassium > 5.4 mmol/L at randomization.
- •- Current hospitalization where patient does not receive treatment for decompensated HF.
- •- Known history of hereditary or idiopathic angioedema or angioedema related to previous ACE inhibitor or ARB therapy
- •- Severe hepatic impairment, biliary cirrhosis and cholestasis
- •- Other protocol-defined exclusion criteria may apply.
研究者
相似试验
进行中（未招募）
1 期
Study to compare Pre-discharge and Post-discharge treatment initiation with LCZ696 therapy in heart failure patients with reduced ejection fraction (HF-rEF) after an acute decompensation eventHeart Failure with reduced ejection fraction (HF-rEF) stabilized after hospitalization due to acute decompensated heart failure episode.MedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2015-003266-87-HUovartis Pharma Services AG1,000
进行中（未招募）
1 期
Study to compare Pre-discharge and Post-discharge treatment initiationwith LCZ696 therapy in heart failure patients with reduced ejection fraction(HF-rEF) after an acute decompensation eventHeart Failure with reduced ejection fraction (HF-rEF) stabilized after hospitalization due to acute decompensated heart failure episode.MedDRA version: 20.0Level: PTClassification code 10007554Term: Cardiac failureSystem Organ Class: 10007541 - Cardiac disordersEUCTR2015-003266-87-ITOVARTIS PHARMA SERVICES AG1,002
进行中（未招募）
1 期
Study to compare Pre-discharge and Post-discharge treatment initiation with LCZ696 therapy in heart failure patients with reduced ejection fraction (HF-rEF) after an acute decompensation eventHeart Failure with reduced ejection fraction (HF-rEF) stabilized after hospitalization due to acute decompensated heart failure episode.MedDRA version: 20.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2015-003266-87-CZovartis Pharma services AG1,000
进行中（未招募）
1 期
Study to compare Pre-discharge and Post-discharge treatment initiation with LCZ696 therapy in heart failure patients with reduced ejection fraction (HF-rEF) after an acute decompensation eventHeart Failure with reduced ejection fraction (HF-rEF) stabilized after hospitalization due to acute decompensated heart failure episode.MedDRA version: 20.0 Level: LLT Classification code 10019279 Term: Heart failure System Organ Class: 100000004849EUCTR2015-003266-87-PTovartis Pharma services AG1,002
进行中（未招募）
1 期
Study to compare Pre-discharge and Post-discharge treatment initiation with LCZ696 therapy in heart failure patients with reduced ejection fraction (HF-rEF) after an acute decompensation eventHeart Failure with reduced ejection fraction (HF-rEF) stabilized after hospitalization due to acute decompensated heart failure episode.MedDRA version: 18.1Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2015-003266-87-ESovartis Farmacéutica S.A.1,000